Literature DB >> 28477575

Conformational heterogeneity in CCR7 undergoes transitions to specific states upon ligand binding.

Zied Gaieb1, Dimitrios Morikis2.   

Abstract

Ligand-binding to G protein-coupled receptors (GPCRs) acts as the local driving force that initiates signal transduction through the receptor and mediates its conformational transitions and interactions with various intracellular effectors. In a recent study, We have shown that the binding of ligands CCL19 and CCL21 to CCR7 induces biased triggering of side chain-based molecular switches, which coordinate concerted transmembrane helical domain motions and transitioning of the receptor to distinct conformational states (Gaieb, Z., D.D. Lo, and D. Morikis. 2016. Molecular Mechanism of Biased Ligand Conformational Changes in CC Chemokine Receptor 7. Journal of Chemical Information and Modeling. 56: 1808-1822, DOI: 10.1021/acs.jcim.6b00367). To complement our previous study, we compare the results of the free (apo) CCR7 microsecond molecular dynamics simulations to those of the ligand-bound CCR7, and show that the apo receptor is found in conformational heterogeneity that only exhibits random fluctuations and lacks the coordinated helical motions seen in ligand-bound receptors. We conclude that ligand binding is responsible for coordinating the stochastic conformational nature of CCR7 into specific conformational states, initiated and propagated by specific physicochemical events.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biased ligands; CC chemokine receptor 7; CCL19 and CCL21; Computational modeling; G protein-coupled receptor; Molecular dynamics

Mesh:

Substances:

Year:  2017        PMID: 28477575     DOI: 10.1016/j.jmgm.2017.04.012

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  2 in total

1.  Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7.

Authors:  Astrid S Jørgensen; Olav Larsen; Edith Uetz-von Allmen; Michael Lückmann; Daniel F Legler; Thomas M Frimurer; Christopher T Veldkamp; Gertrud M Hjortø; Mette M Rosenkilde
Journal:  Front Immunol       Date:  2019-09-13       Impact factor: 7.561

2.  The C-terminal peptide of CCL21 drastically augments CCL21 activity through the dendritic cell lymph node homing receptor CCR7 by interaction with the receptor N-terminus.

Authors:  Astrid Sissel Jørgensen; Emma Probst Brandum; Jeppe Malthe Mikkelsen; Klaudia A Orfin; Ditte Rahbæk Boilesen; Kristoffer Lihme Egerod; Natasha A Moussouras; Frederik Vilhardt; Pawel Kalinski; Per Basse; Yen-Hsi Chen; Zhang Yang; Michael B Dwinell; Brian F Volkman; Christopher T Veldkamp; Peter Johannes Holst; Katharina Lahl; Christoffer Knak Goth; Mette Marie Rosenkilde; Gertrud Malene Hjortø
Journal:  Cell Mol Life Sci       Date:  2021-09-29       Impact factor: 9.207

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.